FDA Orange Book · active-ingredient family
Chlorpropamide
Chlorpropamide: 1 brand, 32 generics; first approved Feb 27, 1984; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 32 ANDA applications approved.
Brands (NDA)
1
Generics (ANDA)
32
Listed patents
0
Presentations
35
Brand (NDA) products
Originator applications
- DIABINESERLDPFIZERNDA 011641—2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — 250MG TABLET ORAL Discontinued —
Generic (ANDA) products (32)
Abbreviated applications
- CHLORPROPAMIDEDAVA PHARMS INCANDA 0895611987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEDAVA PHARMS INCANDA 0895621987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0894461986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0894471986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEHALSEYANDA 0893211986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEHALSEYANDA 0886621986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0889211985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0889221985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0888401984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0888121984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0888131984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0889181984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0889191984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0887681984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - ANI PHARMSANDA 0886411984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 0888261984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEWATSON LABS TEVAANDA 0888521984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEWATSON LABSANDA 0868651984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDESUPERPHARMANDA 0886941984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDESUPERPHARMANDA 0886951984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDERISINGANDA 0887251984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDERISINGANDA 0887261984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEUSL PHARMAANDA 0887081984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEUSL PHARMAANDA 0887091984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEPHARMOBEDIENTANDA 08854919842 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEWATSON LABSANDA 0886081984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEWATSON LABSANDA 0885681984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEPAR PHARMANDA 0881751984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 100MG TABLET ORAL Discontinued — - CHLORPROPAMIDEPAR PHARMANDA 0881761984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEANI PHARMSANDA 087353—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDESANDOZANDA 084669—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - CHLORPROPAMIDEWATSON LABSANDA 086866—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued —
Listed patents
Orange Book patent file
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Approval history
FDA approval span
First approval
43 yr 1 mo ago
Most recent approval
39 yr 7 mo ago
Approvals span 1984–1987 across 33 FDA applications.
Brand (NDA) 13%
Generic (ANDA) 3297%
Chlorpropamide: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
